NCT01062880

Brief Summary

Neuropattern is a first translational tool in stress medicine. Neuropattern is a diagnostic tool, which can be applied by in- and outpatients and physicians to detect dysregulation in the stress response network. The physician provides anamnestic and anthropometric data, while the patient takes other measures at home, e.g. psychological, symptomatic, and biological data. Among the biological data are ECG measures for analyses of heart rate variability, and salivary cortisol measures before and after a dexamethasone challenge test. All data are analyzed in a central laboratory, which generates a written report for the physician, including a disease model, from which personalized recommendations for pharmacological and psychological treatments are derived. Neuropattern additionally offers individualized internet modules to inform the patient about the disease model and to teach him/her what he/she can do to improve his/her medical conditions. The current study applies Neuropattern in 2000 patients of family doctors, suffering from major depression, depressive episodes, adjustment disorders, and somatoform disorders. The patients receive either unspecific or individualized internet modules in a randomized order.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
2,000

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2010

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2010

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

February 3, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 4, 2010

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2011

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2012

Completed
Last Updated

February 4, 2010

Status Verified

October 1, 2009

Enrollment Period

1.2 years

First QC Date

February 3, 2010

Last Update Submit

February 3, 2010

Conditions

Outcome Measures

Primary Outcomes (1)

  • Documentation and distribution of different endophenotypes (Neuropattern) in patients of family doctors suffering from depressive episodes, major depression, somatoform disorders, and adjustment disorders

    15 month

Secondary Outcomes (1)

  • Efficacy of Neuropattern diagnostics with respect to pharmacological treatments and internet based self-guided psychological modules

    1: start of diagnostic testing; 2: after 3 month; 3: after 6 month; 4: after 9 month

Interventions

Patients are assigned at random to either unspecific (n= 1000) or individualized (n=1000) self guided internet modules.

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • native speakers
  • ICD-F diagnoses 32, 33, 43.2, and 45

You may not qualify if:

  • patients under glucocorticoid treatment
  • patients taking antidepressants and anxiolytics
  • patients under psychotherapeutic treatment
  • pregnant women
  • severe medical conditions
  • mental retardation
  • arrhythmia absoluta
  • intolerance of dexamethasone

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Trier, Department of Psychology, Clinical and Physiological Psychology

Trier, 54290, Germany

RECRUITING

Related Publications (3)

  • Hellhammer, D.H., & Hellhammer, J. (Eds.). (2008). Stress: The Brain-Body Connection (Vol. 174). Basel: Karger.

    BACKGROUND
  • Kumsta R, Kliegel D, Linden M, DeRijk R, de Kloet ER. Genetic variation of the mineralocorticoid receptor gene (MR, NR3C2) is associated with a conceptual endophenotype of "CRF-hypoactivity". Psychoneuroendocrinology. 2019 Jul;105:79-85. doi: 10.1016/j.psyneuen.2018.09.036. Epub 2018 Sep 27.

  • Vogt D, Waeldin S, Hellhammer D, Meinlschmidt G. The role of early adversity and recent life stress in depression severity in an outpatient sample. J Psychiatr Res. 2016 Dec;83:61-70. doi: 10.1016/j.jpsychires.2016.08.007. Epub 2016 Aug 7.

MeSH Terms

Conditions

Depressive Disorder, MajorSomatoform DisordersAdjustment Disorders

Condition Hierarchy (Ancestors)

Depressive DisorderMood DisordersMental DisordersTrauma and Stressor Related Disorders

Study Officials

  • Dirk H Hellhammer, Professor, PhD

    University of Trier, Dept. of Psychology

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Dirk H Hellhammer, Professor PhD

CONTACT

Maria Conrad, Secretary

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

February 3, 2010

First Posted

February 4, 2010

Study Start

February 1, 2010

Primary Completion

May 1, 2011

Study Completion

May 1, 2012

Last Updated

February 4, 2010

Record last verified: 2009-10

Locations